Folic Acid Modified Polymeric Micelles for Intravesical Instilled Chemotherapy

Dan-Hua Zhou ,  Guan Zhang ,  Qing-Song Yu ,  Zhi-Hua Gan

Citation:  Dan-Hua Zhou, Guan Zhang, Qing-Song Yu, Zhi-Hua Gan. Folic Acid Modified Polymeric Micelles for Intravesical Instilled Chemotherapy[J]. Chinese Journal of Polymer Science, 2018, 36(4): 479-487. doi: 10.1007/s10118-018-2009-y shu

Folic Acid Modified Polymeric Micelles for Intravesical Instilled Chemotherapy

English


    1. [1]

      Sun P., Zhou D., Gan Z.. Novel reduction-sensitive micelles for triggered intracellular drug release[J]. J. Control. Release, 2011, 155(1):  96-103. doi: 10.1016/j.jconrel.2010.11.005

    2. [2]

      Nie S., Xing Y., Kim G. J., Simons J. W.. Nanotechnology applications in cancer[J]. Annu. Rev. Biomed. Eng., 2007, 9(1):  257-288. doi: 10.1146/annurev.bioeng.9.060906.152025

    3. [3]

      GuhaSarkar S., Banerjee R.. Intravesical drug delivery:challenges, current status, opportunities and novel strategies[J]. J. Control. Release, 2010, 148(2):  147-159. doi: 10.1016/j.jconrel.2010.08.031

    4. [4]

      Shelley M. D., Mason M. D., Kynaston H.. Intravesical therapy for superficial bladder cancer:a systematic review of randomised trials and meta-analyses[J]. Cancer Treat. Rev., 2010, 36(3):  195-205. doi: 10.1016/j.ctrv.2009.12.005

    5. [5]

      Parkin D. M.. The global burden of urinary bladder cancer[J]. Scand. J. Urology Nephr., 2008, 42:  12-20.

    6. [6]

      Ploeg M., Aben K. K. H., Kiemeney L. A.. The present and future burden of urinary bladder cancer in the world[J]. World J. Urology, 2009, 27(3):  289-293. doi: 10.1007/s00345-009-0383-3

    7. [7]

      Beardo V. P., Gamaza M. R., Gavira M. R.. Toxicity of intravesical gemcitabine in superficial bladder cancer treatment[J]. Farm Hosp, 2014, 38(3):  249-251.

    8. [8]

      Rajala P., Liukkonen T., Raitanen M., Rintala E., Kaasinen E., Helle M., Lukkarinen O., Finnbladder G.. Transurethral resection with perioperative instillation of interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer:A prospective randomized multicenter study-finnbladder iii[J]. J. Urology, 1999, 161(4):  1133-1135. doi: 10.1016/S0022-5347(01)61609-4

    9. [9]

      Bellmunt J., Guix M.. New agents for bladder cancer[J]. Ann. Oncol., 2010, 21:  56-58.

    10. [10]

      Li X., Qian Y., Liu T., Hu X., Zhang G., You Y., Liu S.. Amphiphilic multiarm star block copolymer-based multifunctional unimolecular micelles for cancer targeted drug delivery and mr imaging[J]. Biomaterials, 2011, 32(27):  6595-6605. doi: 10.1016/j.biomaterials.2011.05.049

    11. [11]

      Jagur-Grodzinski J.. Polymers for targeted and/or sustained drug delivery, Polym[J]. Adv. Technol.,, 2009, 20(7):  595-606. doi: 10.1002/pat.v20:7

    12. [12]

      Cho H. K., Cheong I. W., Lee J. M., Kim J. H.. Polymeric nanoparticles, micelles and polymersomes from amphiphilic block copolymer[J]. Korean J. Chem. Eng., 2010, 27(3):  731-740. doi: 10.1007/s11814-010-0216-5

    13. [13]

      Li X. R., Li P. Z., Zhang Y. H., Zhou Y. X., Chen X. W., Huang Y. Q., Liu Y.. Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously[J]. Pharm. Res., 2010, 27(8):  1498-1511. doi: 10.1007/s11095-010-0147-1

    14. [14]

      Bilensoy E., Sarisozen C., Esendagl I.G., Dogan A. L., Aktas Y., Sen M., Mungan N.A.. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of mitomycin C to bladder tumors, Int[J]. J. Pharm.,, 2009, 371(1-2):  170-176.

    15. [15]

      Kim S. W., Lee S. J., Cho Y. H., Yoon M. S., Lee C.H.. The anticancer efficacy and toxicity of oral paclitaxel-loaded lipid nanoparticle in a C3H2 bladder cancer mice[J]. Eur. Urology Suppl., 2005, 4(3):  84-84.

    16. [16]

      Zhou D., Zhang G., Gan Z.. c(RGDfk) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer[J]. J. Control. Release, 2013, 169(3):  204-210. doi: 10.1016/j.jconrel.2013.01.025

    17. [17]

      Lu Y. J., Low P. S.. Folate-mediated delivery of macromolecular anticancer therapeutic agents[J]. Adv. Drug Deliv. Rev., 2002, 54(5):  675-693. doi: 10.1016/S0169-409X(02)00042-X

    18. [18]

      Ross J. F., Chaudhuri P. K., Ratnam M.. Differential regulation of folate receptor isoforms in normal and malignant-tissues in vivo and in established cell-lines-physiological and clinical implications[J]. Cancer, 1994, 73(9):  2432-2443. doi: 10.1002/(ISSN)1097-0142

    19. [19]

      Guo X., Shi C., Wang J., Di S., Zhou S.. pH-triggered intracellular release from actively targeting polymer micelles[J]. Biomaterials, 2013, 34(18):  4544-4554. doi: 10.1016/j.biomaterials.2013.02.071

    20. [20]

      Yoo H. S., Park T. G.. Folate receptor targeted biodegradable polymeric doxorubicin micelles[J]. J. Control. Release, 2004, 96(2):  273-283. doi: 10.1016/j.jconrel.2004.02.003

    21. [21]

      Shi C., Guo X., Qu Q., Tang Z., Wang Y., Zhou S.. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles[J]. Biomaterials, 2014, 35(30):  8711-8722. doi: 10.1016/j.biomaterials.2014.06.036

    22. [22]

      Zhang Y., Sun P. J., Gan Z. H.. Biodegradable amphiphilic block copolymers containing functionalized peo blocks:Controlled synthesis and biomedical potentials[J]. Sci. Chi. Chem., 2010, 53(3):  519-527. doi: 10.1007/s11426-010-0095-y

    23. [23]

      Fernandes R. M. F., Marques E. F., Silva B. F. B., Wang Y. J.. Micellization behavior of a catanionic surfactant with high solubility mismatch composition, temperature, and salt effects, J[J]. Mol. Liq.,, 2010, 157(2-3):  113-118. doi: 10.1016/j.molliq.2010.08.014

    24. [24]

      Wei X., Gong C., Gou M., Fu S., Guo Q., Shi S., Luo F., Guo G., Qiu L., Qian Z.. Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system[J]. Int. J. Pharm., 2009, 381(1):  1-18. doi: 10.1016/j.ijpharm.2009.07.033

    25. [25]

      Yu G. Q., Zhang Y., Shi X. D., Li Z. S., Gan Z. H.. Surface property and in vitro biodegradation of microspheres fabricated by poly(ε-caprolactone-b-ethylene oxide) diblock copolymers[J]. J. Biomed. Mater. Res. Part A, 2008, 84A(4):  926-939. doi: 10.1002/(ISSN)1552-4965

    26. [26]

      Lu T. C., Sun J., Chen X. X., Zhang P. B., Jing X. B.. Folate-conjugated micelles and their folate-receptor-mediated endocytosis[J]. Macromol. Biosci., 2009, 9(11):  1059-1068. doi: 10.1002/mabi.v9:11

    27. [27]

      Cho H. K., Lone S., Kim D. D., Choi J. H., Choi S. W., Cho J. H., Kim J. H., Cheong I. W.. Synthesis and characterization of fluorescein isothiocyanate (FITC)-labeled PEO-PCL-PEO triblock copolymers for topical delivery[J]. Polymer, 2009, 50(11):  2357-2364. doi: 10.1016/j.polymer.2009.03.032

    28. [28]

      Liu Y. T., Li K., Pan J., Liu B., Feng S. S.. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of docetaxel[J]. Biomaterials, 2010, 31(2):  330-338. doi: 10.1016/j.biomaterials.2009.09.036

    29. [29]

      Prabaharan M., Grailer J. J., Pilla S., Steeber D. A., Gong S.. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery[J]. Biomaterials, 2009, 30(29):  5757-5766. doi: 10.1016/j.biomaterials.2009.07.020

    30. [30]

      Seow W. Y., Xue J. M., Yang Y. Y.. Targeted and intracellular delivery of Paclitaxel using multi-functional polymeric micelles[J]. Biomaterials, 2007, 28(9):  1730-40. doi: 10.1016/j.biomaterials.2006.11.039

  • 加载中
计量
  • PDF下载量:  0
  • 文章访问数:  2243
  • HTML全文浏览量:  73
文章相关
  • 发布日期:  2018-04-05
  • 收稿日期:  2017-06-28
  • 接受日期:  2017-07-12
  • 网络出版日期:  2018-12-20
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章